Skip to main content
Clinical Trials/NCT04796272
NCT04796272
Terminated
N/A

Role of Individualized Versus Traditional Exercise in Combating Fatigue in Fatigued Multiple Sclerosis Patients

Centre Hospitalier Universitaire de Saint Etienne1 site in 1 country30 target enrollmentApril 2, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Enrollment
30
Locations
1
Primary Endpoint
Chronic fatigue score
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

The objective of this project will be to characterise the benefits of an exercise programme adapted to each individual's abilities compared to a traditional exercise programme with the aim of reducing perceived fatigue and improving the quality of life of Patients with multiple sclerosis.

Detailed Description

Chronic fatigue is a very common symptom reported (80%) by patients with multiple sclerosis (MS), regardless of the type of MS and level of disability. Despite the clinical importance of MS-related fatigue, pharmacological treatments remain quite ineffective in preventing or treating chronic fatigue. Recently, physical activity has proven to be an effective therapy with benefits on chronic fatigue as well as on different functions (muscular, cardiorespiratory, cognitive, etc.). Nevertheless, the effects of physical exercise may vary between MS patients, as MS is a heterogeneous disease and does not affect each individual in the same way. The objective of this project will be to characterise the benefits of an exercise programme adapted to each individual's abilities compared to a traditional exercise programme with the aim of reducing perceived fatigue and improving the quality of life of Patients with multiple sclerosis.

Registry
clinicaltrials.gov
Start Date
April 2, 2021
End Date
June 30, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Aged 18 to 70 years old
  • Male or female
  • With relapsing-remitting multiple sclerosis (RRMS) as defined by McDonald's 2010 criteria.
  • Between 2 and 25 years from the onset of multiple sclerosis
  • With a high level of fatigue, corresponding to a score of Fatigue Severity Scale\> 4 and Fatigue questionnaire \>
  • Expanded Disability Status Scale Score 5
  • Testing ≥ 4 in all leg muscles.
  • Ability to walk for 10 minutes without stopping (self-reported)
  • Affiliates or beneficiaries of a social security scheme
  • Having freely given their written consent after having been informed of the purpose, course of action and potential risks involved

Exclusion Criteria

  • Severe cerebellar spasticity or ataxia in either leg.
  • Abnormal range of motion of the toes and/or ankle.
  • Musculoskeletal injury that interferes with pedaling.
  • High resting heart rate (\>90 beats per minute).
  • Blood pressure \> 144/94 mmHg.
  • Onset of a multiple sclerosis attack within 90 days prior to the study.
  • Recent adjustment of any medication or drugs that may impact on fatigue, or taking stimulants for fatigue (e.g. Modafinil).
  • Taking of neuro-active substances that may impair cortico-spinal excitability (hypnotics, antiepileptics, psychotropic drugs, muscle relaxants) throughout the study period.
  • Contraindication to the application of a magnetic field
  • History of co-morbid disease or conditions that would compromise the subject's safety during the study.

Outcomes

Primary Outcomes

Chronic fatigue score

Time Frame: Month 3

assessed using the Fatigue Severity Scale (FSS) questionnaire before and after an individualized re-training program compared to a traditional re-training program in MS patients.

Secondary Outcomes

  • Analysis overall quality of life : Fatigue questionnaire(Month 3)
  • Analysis overall quality of life : Physical Activity(Month 3)
  • Hematological parameters(Month 3)
  • Inflammatory parameters(Month 3)
  • quality of sleep(Month 3)
  • cortical activation level(Month 3)
  • neuromuscular fatigue of peripheral function(Month 3)
  • cortico-spinal excitability(Month 3)
  • cardiorespiratory fitness(Month 3)
  • Analysis overall quality of life :Quality of Life(Month 3)
  • Analysis overall quality of life :Depression(Month 3)
  • Analysis overall quality of life : Sleep Quality(Month 3)

Study Sites (1)

Loading locations...

Similar Trials